$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
易瑞沙去哪里购买的到呢?
2025-10-19 11:44:20
Check Details
Lorlatinib治疗肺癌患者疗效如何?
2025-10-19 11:44:20
Check Details
易瑞沙如何使用呢?
2025-10-19 11:44:20
Check Details
易瑞沙对肺癌有多大的效果?
2025-10-19 11:44:20
Check Details
Lorlatinib是什么时候上市的?
2025-10-19 11:44:20
Check Details
易瑞沙治疗肺癌患者效果如何?
2025-10-19 11:44:20
Check Details
Lorlatinib医保给报销吗?
2025-10-19 11:44:20
Check Details
Lorlatinib该如何使用呢?
2025-10-19 11:44:20
Check Details
Lorlatinib治疗期间要注意什么事项呢?
2025-10-19 11:44:20
Check Details
Lorlatinib有耐药性没呢?
2025-10-19 11:44:20
Check Details
肺癌第三代抑制剂-Lorbrena
2025-10-19 11:44:20
Check Details
Lorbrena治疗肺癌效果如何?
2025-10-19 11:44:20
Check Details
1
2
...
9500
9501
9502
9503
9504
9505
9506
...
10206
10207
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
2
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
3
Is MDS Targeted Therapy Chemotherapy? Mechanism, Genetic Testing, and Personalized Care Guide
4
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
5
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
6
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
7
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
8
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained
9
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
10
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
11
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
12
Mavacamten (Maifantuo): A Targeted Therapy for Obstructive Hypertrophic Cardiomyopathy